Friedegund Meier

28PUBLICATIONS
168CO-AUTHORS
Sport and exercise nutritionCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Oct 26, 2026
Multidisciplinary Supportive Cancer Care: Nutritional and Exercise Counseling Pathways Using Electronic Patient-Reported Outcomes, Patient Guides, and Tumor Board Decisions.

|Oct 24, 2026
Phase II Study of Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous Cell Carcinoma: Final Analysis.

|Aug 11, 2026
Neoadjuvant Intralesional Daromun (L19IL2/L19TNF) in Resectable Locally Advanced Melanoma: An Update on the Efficacy and Safety Results of the PIVOTAL Phase III Trial.

|Jul 02, 2026
Years of life lost in patients with a false-negative diagnosis of primary melanoma. A prospective study of the German Central Malignant Melanoma Registry involving 9063 patients over 28 years.

|Jun 04, 2026
Intrathecal nivolumab in metastatic solid tumors with leptomeningeal disease: dose escalation part of the multicenter IT-PD1/NOA-26 phase 1 trial.

|Jan 30, 2026
¹H-NMR serum metabolomic profiling from clinical routine identifies signatures of progressive melanoma metastasis.

Frank Friedrich Gellrich, Cosima Hufnagel, Alexander M Funk

Pageof 5

Frequent Collaborators

9 joint publications

Carola Berking

9 joint publications

Dirk Schadendorf

6 joint publications

Jessica Cecile Hassel

6 joint publications

Frank Friedrich Gellrich